Connect with us

Side Effects

University of Arkansas for Medical Science Studies Connection of Chronic CBD Use and Liver Cancer

Denis Mariti

Published

on

University of Arkansas for Medical Science Studies Connection of Chronic CBD Use and Liver Cancer
- Ad -

A new study, published in the Journal Molecules, takes a look at the connection between chronic CBD use among mice and liver cancer. The study, conducted by the Department of Environmental and Occupational Health at the University of Arkansas for Medical Sciences, is titled Hepatotoxicity of a Cannabidiol-Rich Cannabis Extract in the Mouse Model.

According to the study, it’s goal was to investigate

“Cannabidiol (CBD) hepatotoxicity in 8-week-old male B6C3F1 mice. Animals were gavaged with either 0, 246, 738, or 2460 mg/kg of CBD (acute toxicity, 24 h) or with daily doses of 0, 61.5, 184.5, or 615 mg/kg for 10 days (sub-acute toxicity). These doses were the allometrically scaled mouse equivalent doses (MED) of the maximum recommended human maintenance dose of CBD in EPIDIOLEX® (20 mg/kg).”

Even though this trial was conducted on mice, it appears that even in human studies concerning Epidiolex, potential liver damage was an issue.

Igor Koturbash, PhD, who is a lead author of the study, shared with Nutra Ingredients USA, that even GW Pharma’s Epidiolex’s packaging indicates that there is a risk of liver damage. He shared,

“If you look at the Epidolex label, it clearly states a warning for liver injury. It states you have to monitor the liver enzyme levels of the patients. In clinical trials, 5% to 20% of the patients developed elevated liver enzymes and some patients were withdrawn from the trials.”

Denis is one of the most experienced researchers for reviews we have with years of experience in writing about CBD products. He will be one of the most viewed authors due to his own thrill in sharing what he is learning about cannabidiol and supplement use. With a goal of providing clarity within the budding CBD oil industry, Denis will be spending much of the year going through a catalogue of cannabis oil companies in the near future.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com